Trials / Completed
CompletedNCT03159741
Investigation of GLP-2 Mechanism of Action (GA-8)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Glucagon-like peptide-2 (GLP-2) is a naturally occuring hormone secreted to the circulation in response to food ingestion. Previous studies have shown that GLP-2 and incretins inhibit the bone resorption. However, the mechanism is unknown. In the present study we will investigate the mechanism of action using a receptor specific inhibitor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Inhibitor + GLP-2 | Inhibitor and GLP-2 are used as study tools. |
| OTHER | Placebo + GLP-2 | Placebo and GLP-2 are used as study tools. |
| OTHER | Placebo + GIP | Placebo and GIP are used as study tools. |
| OTHER | Placebo + Saline | Placebo |
Timeline
- Start date
- 2017-05-16
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
- First posted
- 2017-05-19
- Last updated
- 2020-01-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03159741. Inclusion in this directory is not an endorsement.